Lepirudin-induced thrombocytopenia following subcutaneous administration
- 1 May 2009
- journal article
- case report
- Published by Oxford University Press (OUP) in American Journal of Health-System Pharmacy
- Vol. 66 (9) , 834-837
- https://doi.org/10.2146/ajhp080223
Abstract
Purpose. A case of lepirudin-induced thrombocytopenia is reported.Keywords
This publication has 12 references indexed in Scilit:
- Biological Relevance of Anti-Recombinant Hirudin Antibodies-Results from In Vitro and In Vivo StudiesSeminars in Thrombosis and Hemostasis, 2002
- Arthus reaction to lepirudin, a new recombinant hirudin, and delayed‐type hypersensitivity to several heparins and heparinoids, with tolerance to its intravenous administrationContact Dermatitis, 2002
- Recombinant hirudin (lepirudin) for the improvement of thrombolysis with streptokinase in patients with acute myocardial infarctionJournal of the American College of Cardiology, 1999
- Lepirudin (Recombinant Hirudin) for Parenteral Anticoagulation in Patients With Heparin-Induced ThrombocytopeniaCirculation, 1999
- Effects of recombinant hirudin (lepirudin) compared with heparin on death, myocardial infarction, refractory angina, and revascularisation procedures in patients with acute myocardial ischaemia without ST elevation: a randomised trialThe Lancet, 1999
- Recombinant Hirudin (Lepirudin) Provides Safe and Effective Anticoagulation in Patients With Heparin-Induced ThrombocytopeniaCirculation, 1999
- Adverse Skin Reactions to Low Molecular Weight HeparinsDrug Safety, 1999
- A method for estimating the probability of adverse drug reactionsClinical Pharmacology & Therapeutics, 1981
- The effect of sulphinpyrazone and other drugs on the platelet response during the acute phase of the active Arthus reaction in guinea pigsThrombosis Research, 1979
- Platelets, arthus-type reactions and inflammatory mediatorsInflammation Research, 1976